Companies / Xilio Therapeutics, Inc. / Activity
Activity — Xilio Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Gsa Capital Partners LLP 13F manager | New | Common Stock | $143 | +17K | 16,946 0.29% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common Stock | $1.0K | +91 | 91 <0.01% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common Stock | $83.9K | +9K | 8,757 0.15% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common Stock | $127.5K | +13K | 13,311 0.23% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | New | Common Stock | $312.8K | +37K | 37,197 0.64% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common Stock | $416.9K | +50K | 49,566 0.86% of shares | low |
| Q2 2026 as of | Merck & Co., Inc. 13F manager | New | Common Stock | $1.02M | +106K | 105,982 1.83% of shares | low |